Patents by Inventor Kenneth M. Bahrt

Kenneth M. Bahrt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7528111
    Abstract: The present invention relates to methods of vaccinating subjects receiving immune modulating therapy, such as soluble CTLA4 molecules, for treatment of immune system diseases mediated by T-cell interactions with B7-positive cells including, but not limited to, autoimmune diseases, immunoproliferative diseases, and immune disorders associated with graft transplantation.
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: May 5, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: George Vratsanos, Francisco Leon, Lee K. Tay, Kenneth M. Bahrt